The estimated Net Worth of Marie J Versen is at least $2.37 Миллион dollars as of 31 January 2005. Marie Versen owns over 21,000 units of Surmodics stock worth over $2,373,964 and over the last 21 years Marie sold SRDX stock worth over $0.
Marie has made over 1 trades of the Surmodics stock since 2005, according to the Form 4 filled with the SEC. Most recently Marie exercised 21,000 units of SRDX stock worth $148,470 on 31 January 2005.
The largest trade Marie's ever made was exercising 21,000 units of Surmodics stock on 31 January 2005 worth over $148,470. On average, Marie trades about 10,500 units every 0 days since 2004. As of 31 January 2005 Marie still owns at least 60,514 units of Surmodics stock.
You can see the complete history of Marie Versen stock trades at the bottom of the page.
Marie's mailing address filed with the SEC is 9924, West 74th Street, Eden Prairie, Hennepin County, Minnesota, 55344, United States of America.
Over the last 21 years, insiders at Surmodics have traded over $26,204,565 worth of Surmodics stock and bought 19,725 units worth $436,251 . The most active insiders traders include Jeffrey C Smith, Gary R Maharaj и Value Lp Starboard Value Gp.... On average, Surmodics executives and independent directors trade stock every 34 days with the average trade being worth of $415,014. The most recent stock trade was executed by Joseph J. Stich on 21 August 2024, trading 21,285 units of SRDX stock currently worth $706,662.
surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.
Surmodics executives and other stock owners filed with the SEC include: